First and second trimester immune biomarkers in preeclamptic and normotensive women

Pregnancy Hypertension

Volumn 6, Issue 4, 2016, Pages 388-393

  Taylor, Brandie D ^a,b   Ness, Roberta B ^c   Klebanoff, Mark A ^d   Zoh, Roger ^a   Bass, Debra ^b   Hougaard, David M ^e   Skogstrand, Kristin ^e   Haggerty, Catherine L ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^e STATENS SERUM INSTITUT   (Denmark)

Author keywords

Inflammation; Preeclampsia; Pregnancy

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN 8;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; CONVULSION; DISEASE ASSOCIATION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HYPERTENSION; LUNG EDEMA; MAJOR CLINICAL STUDY; MATERNAL AGE; OBSTETRIC DELIVERY; OLIGURIA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; SECOND TRIMESTER PREGNANCY; SMOKING; SOCIAL STATUS; YOUNG ADULT; ADOLESCENT; BLOOD; IMMUNOLOGY; PREGNANCY;

ADOLESCENT; ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL5; CYTOKINES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-1BETA; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKIN-6; INTERLEUKIN-8; LYMPHOTOXIN-ALPHA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84994391661     PISSN: 22107789     EISSN: 22107797     Source Type: Journal    
DOI: 10.1016/j.preghy.2016.09.002     Document Type: Article

References (44)

1. [1] Hutcheon, J.A., Lisonkova, S., Joseph, K.S., Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract. Res. Clin. Obstet. Gynaecol. 25:4 (2011), 391–403.
2. [2] American College of Obstetricians and Gynecologists, Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet. Gynecol. 122:5 (2013), 1122–1131.
3. [3] Mincheva-Nilsson, L., Baranov, V., Placenta-derived exosomes and syncytiotrophoblast microparticles and their role in human reproduction: immune modulation for pregnancy success. Am. J. Reprod. Immunol. 72:5 (2014), 440–457.
4. [4] Tannetta, D.S., Dragovic, R.A., Gardiner, C., Redman, C.W., Sargent, I.L., Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin. PLoS ONE, 8(2), 2013, e56754.
5. [5] Roberts, J.M., Lain, K.Y., Recent insights into the pathogenesis of pre-eclampsia. Placenta 23:5 (2002), 359–372.
6. [6] Redman, C.W., Sargent, I.L., Latest advances in understanding preeclampsia. Science 308:5728 (2005), 1592–1594.
7. [7] Szarka, A., Rigo, J. Jr., Lazar, L., Beko, G., Molvarec, A., Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol., 11, 2010, 59.
8. [8] Madazli, R., Aydin, S., Uludag, S., Vildan, O., Tolun, N., Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet. Gynecol. Scand. 82:9 (2003), 797–802.
9. [9] Jonsson, Y., Ruber, M., Matthiesen, L., Berg, G., Nieminen, K., Sharma, S., Ernerudh, J., Ekerfelt, C., Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J. Reprod. Immunol. 70:1–2 (2006), 83–91.
10. [10] Kumar, A., Begum, N., Prasad, S., Agarwal, S., Sharma, S., IL-10, TNF-alpha & IFN-gamma: potential early biomarkers for preeclampsia. Cell Immunol. 283:1–2 (2013), 70–74.
11. [11] Djurovic, S., Clausen, T., Wergeland, R., Brosstad, F., Berg, K., Henriksen, T., Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG 109:7 (2002), 759–764.
12. [12] G.J. Mundim, M.C. Paschoini, E. Araujo Junior, F. Da Silva Costa, V. Rodrigues Junior, Assessment of angiogenesis modulators in pregnant women with pre-eclampsia: a case-control study, Arch. Gynecol. Obstet. 293(2) (2016) 369–375.
13. [13] Lockwood, C.J., Huang, S.J., Chen, C.P., Huang, Y., Xu, J., Faramarzi, S., Kayisli, O., Kayisli, U., Koopman, L., Smedts, D., Buchwalder, L.F., Schatz, F., Decidual cell regulation of natural killer cell-recruiting chemokines: implications for the pathogenesis and prediction of preeclampsia. Am. J. Pathol. 183:3 (2013), 841–856.
14. [14] Siljee, J.E., Wortelboer, E.J., Koster, M.P., Imholz, S., Rodenburg, W., Visser, G.H., de Vries, A., Schielen, P.C., Pennings, J.L., Identification of interleukin-1 beta, but no other inflammatory proteins, as an early onset pre-eclampsia biomarker in first trimester serum by bead-based multiplexed immunoassays. Prenat. Diagn. 33:12 (2013), 1183–1188.
15. [15] Taylor, B.D., Tang, G., Ness, R.B., Olsen, J., Hougaard, D.M., Skogstrand, K., Roberts, J.M., Haggerty, C.L., Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls. Pregn. Hypertens. 6:1 (2016), 72–78.
16. [16] Perez-Sepulveda, A., Torres, M.J., Khoury, M., Illanes, S.E., Innate immune system and preeclampsia. Front. Immunol., 5, 2014, 244.
17. [17] C.W. Redman, I.L. Sargent, Pre-eclampsia, the placenta and the maternal systemic inflammatory response – a review, Placenta 24(Suppl. A) (2003) S21–S27.
18. [18] Mosimann, B., Wagner, M., Poon, L.C., Bansal, A.S., Nicolaides, K.H., Maternal serum cytokines at 30–33 weeks in the prediction of preeclampsia. Prenat. Diagn. 33:9 (2013), 823–830.
19. [19] Haggerty, C.L., Klebanoff, M.A., Panum, I., Uldum, S.A., Bass, D.C., Olsen, J., Roberts, J.M., Ness, R.B., Prenatal infection increases the risk of preeclampsia. Pregn. Hypertens. 3:3 (2013), 151–154.
20. [20] Niswander, K., The Collaborative Perinatal Study of the National Institute of Neurological Diseases and Stroke: The Women and Their Pregnancies. 1972, PA WB Saybders, Philadelphia.
21. [21] Hardy, J.B., The Collaborative Perinatal Project: lessons and legacy. Ann. Epidemiol. 13:5 (2003), 303–311.
22. [22] Myrianthopoulos, N.C., French, K.S., An application of the U.S. Bureau of the census socioeconomic index to a large, diversified patient population. Soc. Sci. Med. 2:3 (1968), 283–299.
23. [23] Skogstrand, K., Thorsen, P., Norgaard-Pedersen, B., Schendel, D.E., Sorensen, L.C., Hougaard, D.M., Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin. Chem. 51:10 (2005), 1854–1866.
24. [24] Taylor, B.D., Holzman, C.B., Fichorova, R.N., Tian, Y., Jones, N.M., Fu, W., Senagore, P.K., Inflammation biomarkers in vaginal fluid and preterm delivery. Hum. Reprod. 28:4 (2013), 942–952.
25. [25] Aye, I.L., Lager, S., Ramirez, V.I., Gaccioli, F., Dudley, D.J., Jansson, T., Powell, T.L., Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways. Biol. Reprod., 90(6), 2014, 129.
26. [26] Martins, T.B., Pasi, B.M., Pickering, J.W., Jaskowski, T.D., Litwin, C.M., Hill, H.R., Determination of cytokine responses using a multiplexed fluorescent microsphere immunoassay. Am. J. Clin. Pathol. 118:3 (2002), 346–353.
27. [27] Whitcomb, B.W., Schisterman, E.F., Luo, X., Chegini, N., Maternal serum granulocyte colony-stimulating factor levels and spontaneous preterm birth. J. Womens Health (Larchmt) 18:1 (2009), 73–78.
28. [28] Whitcomb, B.W., Schisterman, E.F., Klebanoff, M.A., Baumgarten, M., Rhoton-Vlasak, A., Luo, X., Chegini, N., Circulating chemokine levels and miscarriage. Am. J. Epidemiol. 166:3 (2007), 323–331.
29. [29] Stroud, L.R., Solomon, C., Shenassa, E., Papandonatos, G., Niaura, R., Lipsitt, L.P., Lewinn, K., Buka, S.L., Long-term stability of maternal prenatal steroid hormones from the National Collaborative Perinatal Project: still valid after all these years. Psychoneuroendocrinology 32:2 (2007), 140–150.
30. [30] Whitcomb, B.W., Schisterman, E.F., Klebanoff, M.A., Baumgarten, M., Luo, X., Chegini, N., Circulating levels of cytokines during pregnancy: thrombopoietin is elevated in miscarriage. Fertil. Steril. 89:6 (2008), 1795–1802.
31. [31] Myatt, L., Redman, C.W., Staff, A.C., Hansson, S., Wilson, M.L., Laivuori, H., Poston, L., Roberts, J.M., Global, C., Pregnancy, strategy for standardization of preeclampsia research study design. Hypertension 63:6 (2014), 1293–1301.
32. [32] Uh, H.W., Hartgers, F.C., Yazdanbakhsh, M., Houwing-Duistermaat, J.J., Evaluation of regression methods when immunological measurements are constrained by detection limits. BMC Immunol., 9, 2008, 59.
33. [33] Dinse, G.E., Jusko, T.A., Ho, L.A., Annam, K., Graubard, B.I., Hertz-Picciotto, I., Miller, F.W., Gillespie, B.W., Weinberg, C.R., Accommodating measurements below a limit of detection: a novel application of Cox regression. Am. J. Epidemiol. 179:8 (2014), 1018–1024.
34. [34] P.H. Westfall, S.S. Young, Resampling-based Multiple Testing: Examples and Methods for p-value Adjustment, John Wiley and Sons, New York, 1993.
35. [35] Geisert, R., Fazleabas, A., Lucy, M., Mathew, D., Interaction of the conceptus and endometrium to establish pregnancy in mammals: role of interleukin 1beta. Cell Tissue Res. 349:3 (2012), 825–838.
36. [36] Leavey, K., Benton, S.J., Grynspan, D., Kingdom, J.C., Bainbridge, S.A., Cox, B.J., Unsupervised placental gene expression profiling identifies clinically relevant subclasses of human preeclampsia. Hypertension, 2016.
37. [37] Staff, A.C., Benton, S.J., von Dadelszen, P., Roberts, J.M., Taylor, R.N., Powers, R.W., Charnock-Jones, D.S., Redman, C.W., Redefining preeclampsia using placenta-derived biomarkers. Hypertension 61:5 (2013), 932–942.
38. [38] Holder, B.S., Tower, C.L., Jones, C.J., Aplin, J.D., Abrahams, V.M., Heightened pro-inflammatory effect of preeclamptic placental microvesicles on peripheral blood immune cells in humans. Biol. Reprod., 86(4), 2012, 103.
39. [39] Abumaree, M.H., Chamley, L.W., Badri, M., El-Muzaini, M.F., Trophoblast debris modulates the expression of immune proteins in macrophages: a key to maternal tolerance of the fetal allograft?. J. Reprod. Immunol. 94:2 (2012), 131–141.
40. [40] Amash, A., Holcberg, G., Sapir, O., Huleihel, M., Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: effect of magnesium sulfate. J. Interf. Cytokine Res.: Off. J. Int. Soc. Interf. Cytokine Res. 32:9 (2012), 432–441.
41. [41] Christian, L.M., Porter, K., Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index. Cytokine 70:2 (2014), 134–140.
42. [42] Ferguson, K.K., McElrath, T.F., Chen, Y.H., Mukherjee, B., Meeker, J.D., Longitudinal profiling of inflammatory cytokines and C-reactive protein during uncomplicated and preterm pregnancy. Am. J. Reprod. Immunol. 72:3 (2014), 326–336.
43. [43] Kronborg, C.S., Gjedsted, J., Vittinghus, E., Hansen, T.K., Allen, J., Knudsen, U.B., Longitudinal measurement of cytokines in pre-eclamptic and normotensive pregnancies. Acta Obstet. Gynecol. Scand. 90:7 (2011), 791–796.
44. [44] Curry, A.E., Vogel, I., Skogstrand, K., Drews, C., Schendel, D.E., Flanders, W.D., Hougaard, D.M., Thorsen, P., Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors. J. Reprod. Immunol. 77:2 (2008), 152–160.